Abstract. We employ a hybrid diffuse correlation spectroscopy ͑DCS͒ and near-infrared spectroscopy ͑NIRS͒ monitor for neonates with congenital heart disease ͑n =33͒. The NIRS-DCS device measured changes during hypercapnia of oxyhemoglobin, deoxyhemoglobin, and total hemoglobin concentrations; cerebral blood flow ͑rCBF DCS ͒; and oxygen metabolism ͑rCMRO 2 ͒. Concurrent measurements with arterial spin-labeled magnetic resonance imaging ͑rCBF ASL-MRI , n =12͒ cross-validate rCBF DCS against rCBF ASL-MRI , showing good agreement ͑R = 0.7, p = 0.01͒. The study demonstrates use of NIRS-DCS on a critically ill neonatal population, and the results indicate that the optical technology is a promising clinical method for monitoring this population.